The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.

2019 年冠状病毒病 (COVID-19) 大流行使世界各地的医疗保健资源紧张，导致许多机构减少或停止选择性手术。这导致无法及时护理瓣膜性和结构性心脏病患者，可能使这些患者面临心血管不良并发症（包括心力衰竭和死亡）的风险增加。在当前环境下，对这些患者进行有效分类已变得具有挑战性，因为临床医生必须权衡在 COVID-19 大流行期间将易感患者带入医院环境的风险与延迟所需手术的风险。在本文件中，作者提出了如何对需要结构性心脏病干预的患者进行分类的指南，并提供了一个框架，用于决定尽管疫情仍在持续，但何时适合进行干预。作者特别讨论了需要经导管主动脉瓣置换术和经皮二尖瓣修复术的患者的分类。作者还讨论了 COVID-19 大流行期间结构性心脏病团队职能的程序问题和注意事项。